SynBioBeta Speaker
Jessica Owens
Initiate Ventures
Managing Partner
Jessica Owens is a general partner at Initiate Ventures, leading investments in early-stage Tech Bio companies. A seasoned investor, entrepreneur, and scientist, she’s been a founding team member of seven companies, including GRAIL, and was previously an investor at Kleiner Perkins.
SynBioBeta 2026 Tickets are Live
Confirmed Speakers
Sessions Featuring
Jessica
This Year
•
-
Business of Biology
Investor Roundtable Luncheon
Once a year we put the investors in a room by themselves. No startups. No pitches. No slides. Just the people actually moving capital across biotech and synthetic biology, talking honestly about what they're seeing: what's working, what might be overhyped, and where the real opportunities are right now. It's the conversation you can't have when founders are listening. It's invitation-only and space is limited
Get a Ticket
Featuring
Kid Parchariyanon
SeaX Ventures
Managing Partner
Physician-turned VC backing exponential deeptech and synbio.
Jory Bell
Playground Global
General Partner
Top-tier Silicon Valley investor
David Welch
Synthesis Capital
CSO & Co-founder
Alt-protein scientist-investor, ex-Good Food Institute tech strategist.
Shelby Newsad
Compound
Partner
Scientist-turned-investor funding bold biotech bets.
Jessica Owens
Initiate Ventures
Managing Partner
Venture-studio builder, backing tech-bio moonshots.
•
-
Business of Biology
Investor Roundtable Luncheon
Once a year we put the investors in a room by themselves. No startups. No pitches. No slides. Just the people actually moving capital across biotech and synthetic biology, talking honestly about what they're seeing: what's working, what might be overhyped, and where the real opportunities are right now. It's the conversation you can't have when founders are listening. It's invitation-only and space is limited
Get a Ticket
Featuring
Kid Parchariyanon
SeaX Ventures
Managing Partner
Physician-turned VC backing exponential deeptech and synbio.
Jory Bell
Playground Global
General Partner
Top-tier Silicon Valley investor
David Welch
Synthesis Capital
CSO & Co-founder
Alt-protein scientist-investor, ex-Good Food Institute tech strategist.
Shelby Newsad
Compound
Partner
Scientist-turned-investor funding bold biotech bets.
Jessica Owens
Initiate Ventures
Managing Partner
Venture-studio builder, backing tech-bio moonshots.
Session lineup still growing
Get a Ticket
Featuring
Speaker Coming Soon
•
-
Human Health
From Cells to Patients: Solving the Scale Mismatch in Virtual Biology
Drug discovery often measures biology at the cell level while interventions work at the tissue, organ, or whole-patient scale. This mismatch can make accurate cell-level predictions irrelevant in the clinic. This session dives into strategies to bridge that gap: multiscale modeling that nests single-cell dynamics within organ-level simulations, spatial transcriptomics that preserve context, and surrogate models that translate cell-level outputs into clinical biomarkers. Speakers will ask: how do we ensure virtual biology reflects not just what cells do in isolation, but how biology behaves in the real complexity of patients?
Get a Ticket
Featuring
Speaker Coming Soon
